Turkey Anti Aging Therapeutics Market Report 2022 to 2030

Turkey Anti Aging Therapeutics Market Analysis

$ 3999

Turkey anti-aging therapeutics market is projected to grow from $5 Mn in 2022 to $17 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. The emerging development and increased efforts in research for stem cell therapy in Turkey as well as rising disposable incomes in Turkey are responsible for the expansion of the market. The Turkey anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are Gene2info, Turgut Pharmaceuticals, and Biosplice.

ID: IN10TRPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: Turkey AUTHOR: Parul Choudhary

Buy Now

Turkey Anti-Aging Therapeutics Market Executive Summary

The Turkey anti-aging therapeutics market size is at around $5 Mn in 2022 and is projected to reach $17 Mn in 2030, exhibiting a CAGR of 17.03% during the forecast period. Total health spending in Turkey increased by 24.3% over the previous year to $35.6 Bn. The government spent 79.2% ($198 Bn or $28.2 Bn) of the overall health expenditures, while households contributed 16%. 2.6% of spending was covered by insurance firms, and 2.1% by other sources like non-governmental organizations. Hospitals made up the largest portion of the health organizations used to pay for medical services and supplies, with 49.4%. Hospitals were followed by retailers and other medical supply companies with 25.2% each, and ambulatory healthcare services with 10.3%.

For many years, stem cell therapy has been used to treat haematological disorders. Stem cell therapy is now well-known for promoting aesthetic and cosmetic healing. The best place to receive stem cell therapy, hematopoietic stem cell transfusion, embryonic stem cell therapy, and mesenchymal cell therapy is Turkey. Stem cell therapy improves health by restoring damaged tissue, cells, or organs to their normal activities. It is also known as restorative medicine. Cell therapy is the process of triggering the body's natural healing abilities to restore irreversible organs or tissues. A cell type known as stem cells is in charge of the body's repair and healing processes. It implies that all organ cells have the capacity to regenerate. The first structures in the human organism are developed by these stem cells. This is the rationale behind the use of stem cells in various illnesses. Additionally, it promotes the growth of new cells.

Turkey's healthcare system recently gained more credibility. Turkey surpassed the West and emerged as a rising star in Europe's stem cell and cancer therapy fields. According to the head of the World Apheresis Association, Turkey offers Mns of citizens, refugees, and foreigners cutting-edge medical services, such as stem cell therapy. The success of the stem cell and cancer treatment study has led to a sense of accomplishment. It demonstrated the nation's rapid growth in stem cell operations, which increased from 200 to 4500 each year. Turkish stem cell labs are accredited internationally, and the country has also created a social state. Compared to Europe and the USA, people all over the globe prefer Turkey for affordable, high-quality stem cell treatment.

Turkey Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

New technologies and therapies are often developed, and the area of anti-aging therapeutics is constantly changing. These treatments will probably fuel the Turkey anti-aging therapeutics market expansion as they become more broadly accessible. More people are able to purchase anti-aging treatments as Turkey's economy expands. The Turkey anti-aging therapeutics market is likely to expand even more as a result of this. Turkey is now well-known for its expanded research and development (R&D) efforts in stem cell therapy for anti-aging, which is fuelling the market's expansion.

Market Restraints

In Turkey, many anti-aging procedures are not covered by health insurance policies, which may restrict patients' access to them if they cannot afford to pay for them out of pocket. In Turkey, there is presently no particular regulatory framework for anti-aging treatments, which can leave patients uncertain and raise potential safety issues. New anti-aging product development and marketing may become more challenging as a result thus limiting the Turkey anti-aging therapeutics market expansion.

Competitive Landscape

Key Players

Intrafarma Estetik (TUR)
Mayasan (TUR)
Umram (TUR)
Gene2info (TUR)
Turgut Pharmaceuticals (TUR)
Biosplice
Cyclo Therapeutics
Denali Therapeutics
Elysium Health
Genome Protection
GenSight Biologics

Healthcare Policies and Regulatory Landscape

Turkish Medicines and Medical Devices Agency (TTCK) is Turkey's regulating body for drugs and medical equipment. TTCK is in charge of guaranteeing the security, effectiveness, and caliber of medicines, medical equipment, and anti-aging therapeutics in Turkey. TTCK is in charge of approving and registering drugs and medical devices as well as keeping track of their efficacy and safety. Companies must submit their products for review and approval by TTCK in order to sell anti-aging therapeutics in Turkey. Additionally, TTCK supervises the ethical guidelines for the conduct of clinical trials in Turkey and regulates their conduct. Before conducting clinical trials in Turkey, companies must receive TTCK approval and abide by all rules and laws that are relevant. The "Registration Regulation of Human Medicinal Products," which outlines the principles, processes, and policies surrounding the registration of medicines, governs how pharmaceutical products are registered and reviewed in Turkey. Alignment with international standards has been one of the Turkish health authority's major objectives and focus areas in recent decades and the establishment of a strong, high-quality regulatory health organization similar to other, more developed, mature organizations, in order to guarantee patients' prompt access to medications.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.